A researcher and his team with the University of Alberta Faculty of Medicine & Dentistry have discovered a new class of drugs that could one day be used to treat people with hepatitis B. They have also made a similar discovery for the treatment of tuberculosis.
Working with cultures in his lab, Rakesh Kumar and his colleagues have discovered a new class of drugs for hepatitis B that does three important things: it is effective against the normal strain of the hepatitis B virus, it is effective against the drug-resistant strain and it isn’t toxic to healthy cells. He says no one else in the world has identified this class of drugs. These new drugs could be used in combination with other hepatitis B drugs on the market – at the same time, by themselves or one after the other.